Professor | Jianghuai Liu | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Jianghuai Liu

Contact Information

liujianghuai@nju.edu.cn

Language ability

English, Chinese

Province

Jiangsu

University/Lab Affiliation and Title	Nanjing University
Faculty	Medical School
Academic Background & Achievements	1998 - Bachelor's Degree: Nanjing University, Biochemistry 2005 - Ph.D.: Boston University School of Medicine, Biochemistry
Work Experience	2005-2009 - University of Pennsylvania - Postdoctoral Research 2009-present - Nanjing University - PI, Professor at Model Animal Research Institute

University/Lab Affiliation and Title

Nanjing University

Faculty

Medical School

Academic Background & Achievements

Work Experience

2005-2009 - University of Pennsylvania - Postdoctoral Research
2009-present - Nanjing University - PI, Professor at Model Animal Research Institute

Areas of Focus	Immune Surveillance and Tumors Gene Modification and Cell Engineering
Publications	Precise somatic genome editing for treatment of inborn errors of immunity, Meng Q, Sun H* and Liu J, 2023 Enhancement of prime editing via xrRNA motif-joined pegRNA, Zhang G†, Liu Y†, Huang S†, Qu S, Cheng D, Yao Y, Ji Q, Wang X, Huang X* and Liu J, 2022 Precise tumor immune rewiring via synthetic CRISPRa circuits gated by concurrent gain/loss of transcription factors, Wang Y†, Zhang G†, Meng Q†, Huang S, Guo P, Leng Q, Liu G, Huang X* and Liu J, 2022 CRISPR/Cas12a-assisted rapid identification of beer spoilage bacteria, Meng Q†, Yang H†, Zhang G, Ma P, Liu X, Dang L, Li G, Huang X, Wang X, Liu J* and Leng Q, 2021 A monocyte-orchestrated IFN-I-to-IL-4 cytokine axis instigates pro-tumoral macrophages and thwarts poly(I:C) therapy, Gup P†, Yang L†, Zhang M, Zhang Y, Tong Y, Cao Y and Liu J, 2021 Concomitant Type I IFN and M-CSF signaling reprograms monocyte differentiation to drive pro-tumoral arginase production, Tong Y†, Zhou L†, Yang L, Cao Y, Qin FX and Liu J*, 2019

Areas of Focus

Immune Surveillance and Tumors
Gene Modification and Cell Engineering

Publications

Precise somatic genome editing for treatment of inborn errors of immunity, Meng Q, Sun H* and Liu J*, 2023
Enhancement of prime editing via xrRNA motif-joined pegRNA, Zhang G†, Liu Y†, Huang S†, Qu S, Cheng D, Yao Y, Ji Q, Wang X*, Huang X* and Liu J*, 2022
Precise tumor immune rewiring via synthetic CRISPRa circuits gated by concurrent gain/loss of transcription factors, Wang Y†, Zhang G†, Meng Q†, Huang S, Guo P, Leng Q, Liu G*, Huang X* and Liu J*, 2022
CRISPR/Cas12a-assisted rapid identification of beer spoilage bacteria, Meng Q†, Yang H†, Zhang G, Ma P, Liu X, Dang L, Li G, Huang X, Wang X*, Liu J* and Leng Q*, 2021
A monocyte-orchestrated IFN-I-to-IL-4 cytokine axis instigates pro-tumoral macrophages and thwarts poly(I:C) therapy, Gup P†, Yang L†, Zhang M, Zhang Y, Tong Y, Cao Y and Liu J*, 2021
Concomitant Type I IFN and M-CSF signaling reprograms monocyte differentiation to drive pro-tumoral arginase production, Tong Y†, Zhou L†, Yang L, Cao Y, Qin FX and Liu J*, 2019

Immune Surveillance Tumors Gene Modification Cell Engineering Crispr Genome Editing Immunotherapy Cancer Research Biochemistry Cell Biology

Jin Tang Dong - Southern University of Science and Technology

Wanqiu Li - Southern University of Science and Technology

Ming-Yuan Su - Southern University of Science and Technology

View All

Personal Information